Search Results

There are 19700 results for: content related to: Droplet aerodynamics, cellular uptake, and efficacy of a nebulizable corticosteroid nanosuspension are superior to a micronized dosage form

  1. Budesonide for maintenance of remission in Crohn's disease

    Intervention Review

    The Cochrane Library

    M Ellen Kuenzig, Ali Rezaie, Cynthia H Seow, Anthony R Otley, A Hillary Steinhart, Anne Marie Griffiths, Gilaad G Kaplan and Eric I Benchimol

    Published Online : 21 AUG 2014, DOI: 10.1002/14651858.CD002913.pub3

  2. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease

    Intervention Review

    The Cochrane Library

    Kayleigh M Kew and Alieksei Seniukovich

    Published Online : 10 MAR 2014, DOI: 10.1002/14651858.CD010115.pub2

  3. Budesonide for induction of remission in Crohn's disease

    Intervention Review

    The Cochrane Library

    Cynthia H Seow, Eric I Benchimol, Anne Marie Griffiths, Anthony R Otley and A Hillary Steinhart

    Published Online : 16 JUL 2008, DOI: 10.1002/14651858.CD000296.pub3

  4. You have free access to this content
    Cochrane review: Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 5, Issue 3, September 2010, Pages: 1456–1542, Christopher J Cates, Toby J Lasserson and Roman Jaeschke

    Article first published online : 7 OCT 2010, DOI: 10.1002/ebch.583

  5. Oral budesonide for induction of remission in ulcerative colitis

    Intervention Review

    The Cochrane Library

    Mary E Sherlock, Cynthia H Seow, A Hillary Steinhart and Anne Marie Griffiths

    Published Online : 6 OCT 2010, DOI: 10.1002/14651858.CD007698.pub2

  6. Pharmacokinetics of Budesonide and Formoterol Administered Via 1 Pressurized Metered-Dose Inhaler in Patients With Asthma and COPD

    The Journal of Clinical Pharmacology

    Volume 48, Issue 11, November 2008, Pages: 1300–1308, Dr Ann Tronde, Mr Michael Gillen, Dr Lars Borgström, Dr Jan Lötvall and Dr Jaro Ankerst

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008322122

  7. You have free access to this content
    Effects of local and systemic budesonide on allergen-induced airway reactions in the pig

    British Journal of Pharmacology

    Volume 118, Issue 4, June 1996, Pages: 989–997, Cecilia Fornhem, Magnus Dahlbäck, Maria Kumlin, Jan M. Lundberg and Kjell Alving

    Article first published online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1996.tb15497.x

  8. Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults

    Biopharmaceutics & Drug Disposition

    Volume 29, Issue 7, October 2008, Pages: 382–395, Annika Eklund, Ann Tronde, Ingegerd Johannes-Hellberg, Michael Gillen and Lars Borgström

    Article first published online : 11 JUL 2008, DOI: 10.1002/bdd.622

  9. You have free access to this content
    Development of budesonide nanocluster dry powder aerosols: Preformulation

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 9, September 2012, Pages: 3434–3444, Nashwa El-Gendy, Parthiban Selvam, Pravin Soni and Cory Berkland

    Article first published online : 23 MAY 2012, DOI: 10.1002/jps.23197

  10. Efficacy and safety of high-dose budesonide/formoterol (Symbicort®) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma

    Respirology

    Volume 11, Issue 3, May 2006, Pages: 276–286, Christine JENKINS, Renata KOLARIKOVA, Piotr KUNA, Denis CAILLAUD, Joaquin SANCHIS, Wolfgang POPP and Eva PETTERSSON

    Article first published online : 19 APR 2006, DOI: 10.1111/j.1440-1843.2006.00856.x

  11. You have free access to this content
    Budesonide in the treatment of Crohn’s disease: a meta-analysis

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 11, November 2000, Pages: 1419–1428, C. Papi, R. Luchetti, L. Gili, S. Montanti, M. Koch and L. Capurso

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00867.x

  12. You have free access to this content
    Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: Phase III study results

    Respirology

    Volume 18, Issue 2, February 2013, Pages: 354–363, TITO ATIENZA, TERESITA AQUINO, MARCELO FERNÁNDEZ, WATCHARA BOONSAWAT, MITSURU KAWAI, TAKAHIDE KUDO, Jan Ekelund, Stefan Ivanov and Lars-Goran Carlsson

    Article first published online : 25 JAN 2013, DOI: 10.1111/resp.12009

  13. The Oral, Once-Daily Phosphodiesterase 4 Inhibitor Roflumilast Lacks Relevant Pharmacokinetic Interactions With Inhaled Budesonide

    The Journal of Clinical Pharmacology

    Volume 47, Issue 8, August 2007, Pages: 1005–1013, Dr Robert Hermann, Dr Werner Siegmund, Dr Thomas Giessmann, Dr Kristin Westphal, Dr Anita Weinbrenner, Dr Bernhard Hauns, Dr Felix Reutter, Dr Karl Zech, Mr Gezim Lahu and Dr Thomas D. Bethke

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270007300950

  14. You have free access to this content
    Bronchoprotection in conscious guinea pigs by budesonide and the NO-donating analogue, TPI 1020, alone and combined with tiotropium or formoterol

    British Journal of Pharmacology

    Volume 167, Issue 3, October 2012, Pages: 515–526, DL Turner, N Ferrari, WR Ford, EJ Kidd, B Nevin, L Paquet, P Renzi and KJ Broadley

    Article first published online : 5 SEP 2012, DOI: 10.1111/j.1476-5381.2012.02016.x

  15. You have full text access to this OnlineOpen article
    Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma

    International Journal of Clinical Practice

    Volume 61, Issue 11, November 2007, Pages: 1874–1883, A. H. Morice, S. Peterson, O. Beckman and D. Osmanliev

    Article first published online : 10 OCT 2007, DOI: 10.1111/j.1742-1241.2007.01574.x

  16. You have free access to this content
    Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma

    Respirology

    Volume 17, Issue 4, May 2012, Pages: 639–646, MAKOTO HOSHINO and JUNICHI OHTAWA

    Article first published online : 19 APR 2012, DOI: 10.1111/j.1440-1843.2012.02130.x

  17. Preparation of budesonide/γ-cyclodextrin complexes in supercritical fluids with a novel SEDS method

    Journal of Pharmaceutical Sciences

    Volume 95, Issue 10, October 2006, Pages: 2235–2245, Tarja Toropainen, Sitaram Velaga, Teemu Heikkilä, Laura Matilainen, Pekka Jarho, Johan Carlfors, Vesa-Pekka Lehto, Tomi Järvinen and Kristiina Järvinen

    Article first published online : 1 AUG 2006, DOI: 10.1002/jps.20702

  18. You have free access to this content
    Development of budesonide nanocluster dry powder aerosols: Processing

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 9, September 2012, Pages: 3425–3433, Nashwa El-Gendy, Parthiban Selvam, Pravin Soni and Cory Berkland

    Article first published online : 26 APR 2012, DOI: 10.1002/jps.23168

  19. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children

    Intervention Review

    The Cochrane Library

    Christopher J Cates and Toby J Lasserson

    Published Online : 21 JAN 2009, DOI: 10.1002/14651858.CD007085.pub2

  20. You have free access to this content
    Nasal retention of budesonide and fluticasone in man: Formation of airway mucosal budesonide-esters in vivo

    British Journal of Clinical Pharmacology

    Volume 51, Issue 2, February 2001, Pages: 159–163, Hannes Petersen, Annika Kullberg, Staffan Edsbäcker and Lennart Greiff

    Article first published online : 18 DEC 2003, DOI: 10.1111/j.1365-2125.2001.01303.x